Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-TRC-14004392Phase 4Completed
Phase 4, randomised trial of dexmedetomidine (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: interleukin-6, fasting plasma glucose and 1 more. Started Mar 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-TRC-14004392.